Skip to main content

Passage BIO, Inc.

For the period ended Sep 30, 2026. Filed Nov 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 10, 2026

PASG$3.78+10.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​​​​
​​ ​ ​​Page
PART I.​FINANCIAL INFORMATION4
Item 1.​Interim Consolidated Financial Statements (Unaudited)4
​​Consolidated Balance Sheets4
​​Consolidated Statements of Operations and Comprehensive Loss5
​​Consolidated Statements of Stockholders’ Equity6
​​Consolidated Statements of Cash Flows8
​​Notes to Unaudited Interim Consolidated Financial Statements9
Item 2.​Management’s Discussion and Analysis of Financial Condition and Results of Operations27
Item 3.​Quantitative and Qualitative Disclosures About Market Risk40
Item 4.​Controls and Procedures40
PART II.​OTHER INFORMATION41
Item 1.​Legal Proceedings41
Item 1A.​Risk Factors41
Item 2.​Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities46
Item 3.​Defaults Upon Senior Securities46
Item 4.​Mine Safety Disclosures46
Item 5.​Other Information46
Item 6.​Exhibits47
Signatures49
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.